# A Study of MRx-4DP0004 in Asthma

> **NCT03851250** · PHASE1 · TERMINATED · sponsor: **4D pharma plc** · enrollment: 34 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** MRx-4DP0004
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03851250
- **Lead sponsor:** 4D pharma plc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-07-04
- **Primary completion:** 2023-04-26
- **Final completion:** 2023-04-26
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Sponsor insolvency
- **Last updated:** 2024-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03851250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03851250, "A Study of MRx-4DP0004 in Asthma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03851250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*